Multiply Labs

Multiply Labs is a private, San Francisco-based robotics company founded in 2016, operating at the intersection of drug delivery and digital health. Its core offering is a modular robotic platform for the automated, industrial-scale manufacturing of cell and gene therapies, compatible with existing GMP instruments. The company positions itself as a manufacturing partner for the life science industry, targeting the critical bottleneck of scalable production for personalized and complex biologic drugs. It appears to be in a pre-revenue or early-revenue stage, focused on technology development and partnerships.

Modular robotic systems for automated, high-throughput, GMP-compatible manufacturing of cell and gene therapies.

Multiply Labs competes in the emerging field of bioprocess automation. Competitors include large capital equipment and consumables companies (e.g., Thermo Fisher Scientific, Sartorius, Lonza) developing integrated solutions, as well as other robotics-focused startups. Differentiation is based on modularity, flexibility, and throughput via parallel processing.